Experienced in Prader-Willi Syndrome

Juliana Giannetti-Gurgel

Belo Horizonte, MG, BR 
Experienced in Prader-Willi Syndrome
Belo Horizonte, MG, BR 
OverviewLocationsClinical Research

Overview

Juliana Giannetti-Gurgel practices in Belo Horizonte, Brazil. Ms. Giannetti-Gurgel is rated as an Experienced expert by MediFind in the treatment of Prader-Willi Syndrome. Her top areas of expertise are Amyotonia Congenita, Myotonia Congenita, Tubular Aggregate Myopathy, and Congenital Fiber-Type Disproportion.

Her clinical research consists of co-authoring 39 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 1 article in the study of Prader-Willi Syndrome.

Gender
Female

Locations

Belo Horizonte, MG, Brazil
Other Locations
MG, Brazil
Sao Paulo, SP, Brazil
Matao, SP 05508900, Brazil

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Phase 3, Randomized, Double-blind, Placebo-controlled Efficacy and Safety Study of Ataluren in Patients With Nonsense Mutation Duchenne Muscular Dystrophy and Open-Label Extension
A Phase 3, Randomized, Double-blind, Placebo-controlled Efficacy and Safety Study of Ataluren in Patients With Nonsense Mutation Duchenne Muscular Dystrophy and Open-Label Extension
Enrollment Status: Completed
Publish Date: January 18, 2024
Intervention Type: Drug
Study Drug: Ataluren
Study Phase: Phase 3

39 Total Publications

Confirmatory long-term efficacy and safety results of ataluren in patients with nmDMD from Study 041, an international, randomized, double-blind, placebo-controlled, Phase III trial.
Confirmatory long-term efficacy and safety results of ataluren in patients with nmDMD from Study 041, an international, randomized, double-blind, placebo-controlled, Phase III trial.
Journal: Journal of comparative effectiveness research
Published: August 22, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Giannetti-Gurgel's expertise for a condition
ConditionClose
    View All 29 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile